NPM1 and acute myeloid leukemia: In NPM1-mutated AML, for instance, detection of mutant NPM1 transcripts by sensitive quantitative RT-PCR after 2 cycles of chemotherapy had an 86% cumulative incidence of relapse vs 34% for NPM1 negative patients [56•].